| Issue |
Title |
File |
| Vol 24, No 9 (2024) |
Cordyceps militaris: A Comprehensive Study on Laboratory Cultivation and Anticancer Potential in Dalton's Ascites Lymphoma Tumor Model |
(Eng)
|
|
Dutta D., Singh N., Aggarwal R., Verma A.
|
| Vol 25, No 11 (2025) |
Corrigendum to: “An Overview of Conventional Drugs and Nanotherapeutic Options for the Treatment and Management of Pediatric Acute Lymphoblastic Leukemia” |
(Eng)
|
|
Yonan A., Jacques C., Fletcher T., Suk-in T., Campbell R.
|
| Vol 25, No 12 (2025) |
Corrigendum to: Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling |
(Eng)
|
|
Zhang L., Chen J., Chen Y., Zou D., Pu Y., Wei M., Huang Y., Li Y., Huang Q., Chen J.
|
| Vol 23, No 11 (2023) |
Corrigendum to: Editorial: Anticancer Platinum Complexes - State of the Art and Future Prospects |
(Eng)
|
|
Galanski M.
|
| Vol 24, No 5 (2024) |
Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells |
(Eng)
|
|
Heidari Majd M., Guo X.
|
| Vol 23, No 11 (2023) |
Corrigendum to: Searching for the Magic Bullet: Anticancer Platinum Drugs Which Can Be Accumulated or Activated in the Tumor Tissue |
(Eng)
|
|
Galanski M., Keppler B.
|
| Vol 23, No 10 (2023) |
Coumarin and Piperazine Conjugates as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII Isoforms |
(Eng)
|
|
Sethi A., Munagalasetty S., Arifuddin M., Carradori S., Supuran C., Alvala R., Alvala M.
|
| Vol 15, No 8 (2015) |
Coumarin: A Promising Scaffold for Anticancer Agents |
(Eng)
|
|
Kaur M., Kohli S., Sandhu S., Bansal Y., Bansal G.
|
| Vol 24, No 1 (2024) |
Coumarin-derived Hydroxamic Acids as Histone Deacetylase Inhibitors: A Review of Anti-cancer Activities |
(Eng)
|
|
Khai N.Q., Vu T.K.
|
| Vol 23, No 10 (2023) |
Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII |
(Eng)
|
|
Redij A., Carradori S., Petreni A., Supuran C., Toraskar M.
|
| Vol 12, No 6 (2012) |
Cranberry as Promising Natural Source of Potential Anticancer Agents: Current Evidence and Future Perspectives |
(Eng)
|
|
Katsargyris A., Tampaki E., Giaginis C., Theocharis S.
|
| Vol 24, No 3 (2024) |
CRD-BP as a Tumor Marker of Colorectal Cancer |
(Eng)
|
|
Fen-Xu ., Jiang L., Chen-Fu ., Feng W., Zhou C.
|
| Vol 23, No 17 (2023) |
Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways |
(Eng)
|
|
Hosseini S., Nazifi P., Amini M., Zargari F., Yari A., Baradaran B., Mahboob S., Mokhtarzadeh A.
|
| Vol 24, No 6 (2024) |
Cryptolepine Analog Exhibits Antitumor Activity against Ehrlich Ascites Carcinoma Cells in Mice via Targeting Cell Growth, Oxidative Stress, and PTEN/Akt/mTOR Signaling Pathway |
(Eng)
|
|
El-Aarag B., Shalaan E., Ahmed A., El Sayed I., Ibrahim W.
|
| Vol 14, No 8 (2014) |
Cucurbitacin B Induces DNA Damage, G2/M Phase Arrest, and Apoptosis Mediated by Reactive Oxygen Species (ROS) in Leukemia K562 Cells |
(Eng)
|
|
Guo J., Zhao W., Hao W., Ren G., Lu J., Chen X.
|
| Vol 25, No 13 (2025) |
Cucurbitacin E Glucoside as an Apoptosis Inducer in Melanoma Cancer Cells by Modulating AMPK/PGK1/PKM2 Pathway |
(Eng)
|
|
Hussein M., Sallam A., Mohamed S., Abdel-Rady A., Maghrabe A., Soltan A., Abdelhamid H., Eldesoky G., Alam S., Islam M.
|
| Vol 13, No 6 (2013) |
Cucurmosin Kills Human Pancreatic Cancer SW-1990 Cells in vitro and in vivo |
(Eng)
|
|
Xie J., Wang C., Yang A., Zhang B., Yin Q., Huang H., Chen M.
|
| Vol 25, No 5 (2025) |
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential |
(Eng)
|
|
Schiavoni V., Emanuelli M., Sartini D., Salvolini E., Pozzi V., Campagna R.
|
| Vol 12, No 3 (2012) |
Curcumin and its Formulations: Potential Anti-Cancer Agents |
(Eng)
|
|
Ji J., Huang X., Zhu H.
|
| Vol 15, No 5 (2015) |
Curcumin as an Adjuvant to Breast Cancer Treatment |
(Eng)
|
|
Kumar P., Kadakol A., Shasthrula P., Mundhe N., Jamdade V., Barua C., Gaikwad A.
|
| Vol 13, No 10 (2013) |
Curcumin Potentiates The Ability of Sunitinib to Eliminate the VHL-lacking Renal Cancer Cells 786-O: Rapid Inhibition of Rb Phosphorylation as a Preamble to Cyclin D1 Inhibition |
(Eng)
|
|
Debata P., Begum S., Mata A., Genzer O., Kleiner M., Banerjee P., Castellanos M.
|
| Vol 24, No 2 (2024) |
Curcumin Suppresses M2 Macrophage-derived Paclitaxel Chemoresistance through Inhibition of PI3K-AKT/STAT3 Signaling |
(Eng)
|
|
Deswal B., Bagchi U., Kapoor S.
|
| Vol 14, No 6 (2014) |
Curcumin: A Promising Agent Targeting Cancer Stem Cells |
(Eng)
|
|
Zang S., Liu T., Shi J., Qiao L.
|
| Vol 15, No 2 (2015) |
Curcumin-Based Anti-Prostate Cancer Agents |
(Eng)
|
|
Chen Q.
|
| Vol 12, No 6 (2012) |
Current and Emerging Strategies in Bladder Cancer |
(Eng)
|
|
Carradori S., Cristini C., Secci D., Gulia C., Gentile V., Battista Di Pierro G.
|
| Vol 25, No 5 (2025) |
Current Insights into Therapeutic Potential of Terpenoids as Anticancer Agents |
(Eng)
|
|
Sahoo B., Banik B., Sharma S., Singh B.
|
| Vol 15, No 7 (2015) |
Current Molecularly Targeting Therapies in NSCLC and Melanoma |
(Eng)
|
|
Rajanna S., Rastogi I., Wojdyla L., Furo H., Kulesza A., Lin L., Sheu B., rakes M., Ivanovich M., Puri N.
|
| Vol 15, No 8 (2015) |
Current Perspective of Natural Alkaloid Carbazole and its Derivatives as Antitumor Agents |
(Eng)
|
|
Shaikh M., Karpoormath R., Thapliyal N., Rane R., Palkar M., Faya A., Patel H., Alwan W., Jain K., Hampannavar G.
|
| Vol 14, No 4 (2014) |
Current View on the Mechanism of Action of Perifosine in Cancer |
(Eng)
|
|
Fensterle J., Aicher B., Seipelt I., Teifel M., Engel J.
|
| Vol 16, No 1 (2016) |
CXCR4 and Glioblastoma |
(Eng)
|
|
Richardson P.
|
| Vol 24, No 18 (2024) |
Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway |
(Eng)
|
|
Li L., Li C., Miao F., Chen W., Kong X., Ye R., Wang F.
|
| Vol 25, No 12 (2025) |
Cyclic Lipopeptides as Selective Anticancer Agents: In vitro Efficacy on B16F10 Mouse Melanoma Cells |
(Eng)
|
|
Hmedat A., Morejon M., Rivera D., Pantelic N., Wessjohann L., Kaluderovic G.
|
| Vol 23, No 9 (2023) |
CYP1B1: A Promising Target in Cancer Drug Discovery |
(Eng)
|
|
Fabris M., Luiza Silva M., de Santiago-Silva K.M., de Lima Ferreira Bispo M., Goes Camargo P.
|
| Vol 14, No 1 (2014) |
CYP24A1 as a Potential Target for Cancer Therapy |
(Eng)
|
|
Sakaki T., Yasuda K., Kittaka A., Yamamoto K., Chen T.
|
| Vol 14, No 1 (2014) |
CYP24A1 as a Potential Target for Cancer Therapy |
(Eng)
|
|
Sakaki T., Yasuda K., Kittaka A., Yamamoto K., Chen T.
|
| Vol 15, No 2 (2015) |
Cystine Dimethyl Ester Induces Apoptosis Through Regulation of PKC-δ and PKC-ε in Prostate Cancer Cells |
(Eng)
|
|
Gurbuz N., Park M., Dent P., Abdel Mageed A., Sikka S., Baykal A.
|
| Vol 14, No 1 (2014) |
Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways |
(Eng)
|
|
Slominski A., Zmijewski M., Semak I., Zbytek B., Pisarchik A., Li W., Zjawiony J., Tuckey R.
|
| Vol 14, No 1 (2014) |
Cytochromes P450 and Skin Cancer: Role of Local Endocrine Pathways |
(Eng)
|
|
Slominski A., Zmijewski M., Semak I., Zbytek B., Pisarchik A., Li W., Zjawiony J., Tuckey R.
|
| Vol 13, No 1 (2013) |
Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics |
(Eng)
|
|
Kanakkanthara A., H. Teesdale-Spittle P., H. Miller J.
|
| Vol 23, No 20 (2023) |
Cytotoxic and Apoptotic Impacts of Ceranib-2 on RAW 264.7 Macrophage Cells |
(Eng)
|
|
Alanyalı f., Algı O.
|
| Vol 15, No 9 (2015) |
Cytotoxic, Antiproliferative and Apoptotic Effects of New Benzimidazole Derivatives on A549 Lung Carcinoma and C6 Glioma Cell Lines |
(Eng)
|
|
Yurttas L., Demirayak S., Ciftci G.
|
| Vol 11, No 3 (2011) |
Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines |
(Eng)
|
|
J. Kapadia G., A. Azuine M., Subba Rao G., Arai T., Iida A., Tokuda H.
|
| Vol 25, No 12 (2025) |
Cytotoxic Effects of Lecaniodiscus Cupanioides (Planch.) Extract and Triterpenoids-derived Gold Nanoparticles On MCF-7 Breast Cancer Cell Lines |
(Eng)
|
|
Magadani R., Ndinteh D., Roux S., Nangah L., Atangwho I., Uti D., Alum E., Egba S.
|
| Vol 14, No 1 (2014) |
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells |
(Eng)
|
|
Sagar S., Esau L., Moosa B., Khashab N., Bajic V., Kaur M.
|
| Vol 14, No 1 (2014) |
Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells |
(Eng)
|
|
Sagar S., Esau L., Moosa B., Khashab N., Bajic V., Kaur M.
|
| Vol 13, No 3 (2013) |
Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line |
(Eng)
|
|
T. Lima R., A. Barron G., A. Grabowska J., Bermano G., Kaur S., Roy N., Helena Vasconcelos M., K.T. Lin P.
|
| Vol 14, No 5 (2014) |
Damnacanthal: A Promising Compound as a Medicinal Anthraquinone |
(Eng)
|
|
Abu N., Ali N., Ho W., Yeap S., Aziz M.Y., Alitheen N.
|
| Vol 13, No 10 (2013) |
Dendrimer-Curcumin Conjugate: A Water Soluble and Effective Cytotoxic Agent Against Breast Cancer Cell Lines |
(Eng)
|
|
Debnath S., Saloum D., Dolai S., Sun C., Averick S., Raja K., Fata J.
|
| Vol 15, No 1 (2015) |
Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells |
(Eng)
|
|
Benzina S., Harquail J., Jean S., Beauregard A., Colquhoun C., Carroll M., Bos A., Gray C., Robichaud G.
|
| Vol 13, No 7 (2013) |
Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment |
(Eng)
|
|
Ahmad A., Biersack B., Li Y., Kong D., Bao B., Schobert R., Padhye S., Sarkar F.
|
| Vol 14, No 6 (2014) |
Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines |
(Eng)
|
|
Pal T., Joshi H., Ramaa C.
|
| Vol 23, No 16 (2023) |
Design and Evaluation of SLNs Encapsulated Curcumin-based Topical Formulation for the Management of Cervical Cancer |
(Eng)
|
|
Singhai M., Pandey V., Ashique S., Gupta G., Arora D., Haider T., Mishra N.
|
| Vol 24, No 4 (2024) |
Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors |
(Eng)
|
|
Banjare L.
|
| Vol 25, No 18 (2025) |
Design and Synthesis of 2-substituted [1,2,4]Triazolo[1,5-a]pyrimidines Tethered with Umbelliferone as Selective Carbonic Anhydrase IX and XII Inhibitors |
(Eng)
|
|
Romagnoli R., Romagnoli E., Brancale A., Supuran C., Nocentini A., Manfreda L., Zanolli A., Bortolozzi R., Viola G.
|
| Vol 24, No 7 (2024) |
Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents |
(Eng)
|
|
Mohamed-Ezzat R., Srour A.
|
| Vol 15, No 5 (2015) |
Design and Synthesis of Novel Antineoplastic Agents Inspired from Marine Bromopyrrole Alkaloids |
(Eng)
|
|
Rane R., Bangalore P., Naphade S., Patel H., Palkar M., Karpoormath R.
|
| Vol 16, No 11 (2016) |
Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro & In Vivo Screening, Docking Analysis |
(Eng)
|
|
Dube P., Mokale S.
|
| Vol 23, No 15 (2023) |
Design of Novel Imidazopyrazine Derivative against Breast Cancer via Targeted NPY1R Antagonist |
(Eng)
|
|
Niranjan V., R V., Philip S., Uttarkar A., Kusanur R., Kumar J.
|
| Vol 12, No 7 (2012) |
Design of N-substituted Amino Caproic Hydroxamic Acid Histone Deacetylase Inhibitors Reveal an Essential Role for Cap Atomic Composition |
(Eng)
|
|
M. Brunel J., Salmi-Smail C., Restouin A., Prebet T., Vey N., Collette Y.
|
| Vol 24, No 6 (2024) |
Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid |
(Eng)
|
|
Li H., Lin H., Li J., Chen K., Chen Z., Zhang J., Huang Y., Zhao X., Ti H., Tao Y.
|
| Vol 23, No 17 (2023) |
Design, Synthesis, and Antiproliferative Activity of Quinazolin-4-One/Chalcone Hybrids via the EGFR Inhibition Pathway |
(Eng)
|
|
Hisham M., Hassan H., Gomaa H., Youssif B., Hayalah A., Abdel-Aziz M.
|
| Vol 23, No 14 (2023) |
Design, Synthesis, and Anti-tumor Activity of Novel 2-Aryl Benzimidazole Compounds |
(Eng)
|
|
Xiaohelaiti H., Wu W., Gao Y., Li S., Ma C.
|
| Vol 15, No 2 (2015) |
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors |
(Eng)
|
|
Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.
|
| Vol 15, No 9 (2015) |
Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents |
(Eng)
|
|
Xiong P., Wang R., Zhang X., DeLa Torre E., Leon F., Zhang Q., Zheng S., Wang G., Chen Q.
|
| Vol 24, No 6 (2024) |
Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold |
(Eng)
|
|
Alimujiang Y., Maimaiti A., Ablise M., Yang Z., Liu Z., Wang Y., Mutalipu Z., Yan T.
|
| Vol 25, No 14 (2025) |
Design, Synthesis, and Molecular Docking Studies of Indolo[3,2-c]Quinolines as Topoisomerase Inhibitors |
(Eng)
|
|
Badr M., Elmongy E., Sayed I., Moemen Y., Khalil A., Elkhateeb D., Binsuwaidan R., Ali H.
|
| Vol 24, No 7 (2024) |
Design, Synthesis, In vitro and In vivo Evaluation of New Imidazo[1,2-a]pyridine Derivatives as Cyclooxygenase-2 Inhibitors |
(Eng)
|
|
Ahmadi N., Khoramjouy M., Azami Movahed M., Amidi S., Faizi M., Zarghi A.
|
| Vol 15, No 10 (2015) |
Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy |
(Eng)
|
|
Poletaev A., Pukhalenko A., Kukushkin A., Sviridov P.
|
| Vol 24, No 11 (2024) |
Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) |
(Eng)
|
|
Zhao Z., Pu Q., Sun T., Huang Q., Tong L., Fan T., Kang J., Chen Y., Zhang Y.
|
| Vol 12, No 10 (2012) |
Developing Phytoestrogens for Breast Cancer Prevention |
(Eng)
|
|
M. Liu M., Huang Y., Wang J.
|
| Vol 11, No 7 (2011) |
Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy |
(Eng)
|
|
Wee Ma W.
|
| Vol 15, No 5 (2015) |
Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance |
(Eng)
|
|
Karthikeyan S., Hoti S.
|
| Vol 12, No 1 (2012) |
Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging |
(Eng)
|
|
E. Wang R., Niu Y., Wu H., Hu Y., Cai J.
|
| Vol 23, No 11 (2023) |
Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and in-vitro Screening |
(Eng)
|
|
Chinchilli K., Singh P., Swain B., Goud N., Sigalapalli D., Choli A., Angeli A., Nanduri S., Yaddanapudi V., Supuran C., Arifuddin M.
|
| Vol 24, No 5 (2024) |
Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MG Glioblastoma Cells via NF-κB and MAPK Signaling Pathways |
(Eng)
|
|
Ai J., Weng Y., Jiang L., Liu C., Liu H., Chen H.
|
| Vol 16, No 10 (2016) |
Diazenyl Derivatives and their Complexes as Anticancer Agents |
(Eng)
|
|
Kaur H., Yadav S., Narasimhan B.
|
| Vol 15, No 4 (2015) |
Different 6-Aryl-Fulvenes Exert Anti-proliferative effects on Cancer Cells |
(Eng)
|
|
Sirignano E., Pisano A., Caruso A., Saturnino C., Sinicropi M., Lappano R., Botta A., Iacopetta D., Maggiolini M., Longo P.
|
| Vol 13, No 4 (2013) |
Differential Binding Preference of Methylpheophorbide a and Its Diboronated Derivatives to Albumin and Low Density Lipoproteins |
(Eng)
|
|
V. Golovina G., N. Rychkov G., A. Ol'shevskaya V., V. Zaitsev A., N. Kalinin V., A. Kuzmin V., A. Shtil A.
|
| Vol 14, No 10 (2014) |
Differential Effects of Antofine N-Oxide on Solid Tumor and Leukemia Cells |
(Eng)
|
|
Bour T., Yang X., Li W., Bernardin F., Kaoma T., Muller A., Vallar L., Steinmetz A.
|
| Vol 13, No 10 (2013) |
Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines |
(Eng)
|
|
Mahbub A., Maitre C., Haywood-Small S., McDougall G., Cross N., Jordan-Mahy N.
|
| Vol 12, No 7 (2012) |
Differential Expressions of Matrix Metalloproteinases, A Disintegrin and Metalloproteinases, and a Disintegrin and Metalloproteinases with Thrombospondin Motifs and their Endogenous Inhibitors Among Histologic Subtypes of Lung Cancers |
(Eng)
|
|
Hida Y., Hamada J.
|
| Vol 15, No 4 (2015) |
Differential Interactions of Cytochrome P450 3A5 and 3A4 with Chemotherapeutic Agent-Vincristine: A Comparative Molecular Dynamics Study |
(Eng)
|
|
Saba N., Bhuyan R., Nandy S., Seal A.
|
| Vol 14, No 8 (2014) |
Differential Role of Apoptosis and Autophagy Associated with Anticancer Effect of Lupulone (Hop β-Acid) Derivatives on Prostate Cancer Cells |
(Eng)
|
|
Mouratidis P., Colston K., Charolidi N., Pirianov G.
|
| Vol 14, No 8 (2014) |
Dinuclear Berenil-Platinum (II) Complexes as Modulators of Apoptosis in Human MCF-7 and MDA-MB231 Breast Cancer Cells |
(Eng)
|
|
Agnieszka G., Ewa A., Anna B., Krzysztof B., Monika C., Elzbieta S.
|
| Vol 23, No 14 (2023) |
Diosgenin Glucoside Inhibits the Progression of Osteosarcoma MG-63 by Regulating the PI3K/AKT/mTOR Pathway |
(Eng)
|
|
Ruan S., Gu L., Wang Y., Huang X., Cao H.
|
| Vol 24, No 4 (2024) |
Discovery and Development of Promising Anticancer Agents via Computational and Experimental |
(Eng)
|
|
Carradori S.
|
| Vol 13, No 10 (2013) |
Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization |
(Eng)
|
|
Provot O., Hamze A., Peyrat J., Brion J., Alami M.
|
| Vol 25, No 8 (2025) |
Discovery of a Novel Co-crystal of Chrysin and Oroxylin A with Anticancer Properties from Leaves of Oroxylum indicum |
(Eng)
|
|
Singh S., Singh A., Singh A., Devi A., Korimayum M., Singh L.
|
| Vol 10, No 9 (2010) |
Discovery of Allosteric Inhibitors of Kinesin Spindle Protein (KSP) for the Treatment of Taxane-Refractory Cancer: MK-0731 and Analogs |
(Eng)
|
|
D. Cox C., M. Garbaccio R.
|
| Vol 23, No 18 (2023) |
Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies |
(Eng)
|
|
Dhawale S., Dabhade P., Mokale S.
|
| Vol 15, No 4 (2015) |
Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers |
(Eng)
|
|
Lo W., Chou Y., Tseng C., Shiu Y., Chen Y., Yang S., Chen Y., Lin M., Tzeng C.
|
| Vol 13, No 9 (2013) |
Discovery of P3971 an Orally Efficacious Novel Anticancer Agent Targeting HIF-1α and STAT3 Pathways |
(Eng)
|
|
Godse P., Kumar P., Yewalkar N., Deore V., Lohar M., Mundada R., Padgaonkar A., Manohar S., Joshi A., Bhatia D., Desai N., Damre A., Bhonde M., Joshi K., Sharma R., Kumar S.
|
| Vol 10, No 1 (2010) |
Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates |
(Eng)
|
|
Underiner T., Herbertz T., Miknyoczki S.
|
| Vol 16, No 11 (2016) |
Disulfiram's Anticancer Activity: Evidence and Mechanisms |
(Eng)
|
|
Jiao Y., Hannafon B., Ding W.
|
| Vol 23, No 14 (2023) |
Diterpenoid Tanshinone Attenuates the Metastasis of Non-small-cell Lung Cancer (NSCLC) Cells by Inhibiting the Cavin-1-mediated ERK/Smad2 Signaling Pathway |
(Eng)
|
|
Wang L., Jiang G., Li X.
|
| Vol 15, No 1 (2015) |
DNA Binding and Anticancer Activity of Novel Cyclometalated Platinum (II) Complexes |
(Eng)
|
|
Nabavizadeh S., Rashidi M., Mohammadi R., Yousefi R., Aseman M.
|
| Vol 13, No 2 (2013) |
DNA Methylation as a Target of Epigenetic Therapeutics in Cancer |
(Eng)
|
|
K. Li K., Li F., S. Li Q., Yang K., Jin B.
|
| Vol 16, No 11 (2016) |
Docking Studies of Glutamine Valproic Acid Derivative (S)-5- amino-2-(heptan-4-ylamino)-5-oxopentanoic Acid (Gln-VPA) on HDAC8 with Biological Evaluation in HeLa Cells |
(Eng)
|
|
Martínez-Ramos F., Luna-Palencia G., Vásquez-Moctezuma I., Méndez-Luna D., Fragoso-Vázquez M., Trujillo-Ferrara J., Meraz-Ríos M., Mendieta-Wejebe J., Correa-Basurto J.
|
| Vol 11, No 2 (2011) |
Does More MnSOD Mean More Hydrogen Peroxide? |
(Eng)
|
|
Ann MacMillan-Crow L., P. Crow J.
|
| Vol 25, No 4 (2025) |
Doramectin Induces Apoptosis in B16 Melanoma Cells |
(Eng)
|
|
Crotts M., Jacobs J., Baer R., Cox J.
|
| 301 - 400 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
